Science Reveals Key Driver of Alzheimer's, and How Newly Approved Drug May Fight It

WEDNESDAY, May 10, 2023 (HealthDay News) -- Researchers have isolated for the first time a free-floating form of amyloid beta that appears to be a key driver of Alzheimer’s disease.

Related Keywords

New York ,United States ,Boston ,Massachusetts ,United Kingdom ,Heather Snyder ,Sam Gandy ,Dennis Selkoe ,United Kingdom Medical Research Council ,Us National Institutes Of Health ,Alzheimer Association ,Women Hospital Center ,Drug Administration ,Us Centers For Medicare ,Mount Sinai Alzheimer Disease Research Center ,Healthday News ,Hospital Center ,Neurologic Diseases ,Mount Sinai Alzheimer ,Disease Research Center ,United Kingdom Medical Research ,Consumer News ,